Insulin controls carbohydrate metabolism in the body; it is a peptide hormone which causes skeletal muscle cells and fat tissues to absorb glucose from the blood. The global human insulin market is valued at $37.14 Billion in 2017 and is estimated to reach $59.93 Billion by 2025 at a CAGR of 8.3% during 2019-2025. The market growth is primarily attributed by the factors such as the growing prevalence of diabetes, changing lifestyles, growing number of obese people as well as geriatric population. However, stringent regulatory requirements for product approvals and high product manufacturing costs are the major restraints obstructing the growth of the human insulin market. Pipeline insulin products and untapped emerging economies are offering significant market opportunities to the market growth during the forecast period 2019-2025.
Research Study Objectives:
- Define, estimate, and forecast the human insulin market statistics by product type, type, brand, delivery services, application and regions concerning the individual growth drivers, market trends and their contribution toward the human insulin market growth.
- Provides comprehensive information regarding the key factors influencing the market growth (Drivers, Restraints & Challenges, and Opportunities).
- Estimate & forecast the market size of all the segments concerning geographies including North America, Europe, Asia Pacific (APAC), South America and the Middle East and Africa (MEA).
- Recent competitive developments including M&A (Mergers and Acquisitions), Partnerships, and Product Innovations are provided in the Human Insulin Market Analysis
- Analysis and conclusions on the future Human insulin market outlook.
Top-down and bottom-up approaches are used to validate the human insulin market size and are used to estimate the size of other dependent submarkets. Key players in the market are identified through various secondary sources; databases including Bloomberg Businessweek, Hoovers, Factiva, journals and associations and the market
revenues are estimated and are thoroughly validated through primary and secondary research. Secondary research involves the study of annual and financial reports of top players in the market, whereas primary research includes extensive interviews with the KoL’s such as CEOs, directors, board members, VP’s, sales managers, engineers, marketing executives, technicians, account managers, investors, strategic decision makers and others. The human insulin market shares and breakdowns are determined using secondary sources and are verified by the primary sources. All possible parameters/factors that are affecting the Human insulin market demand are covered in the research study are verified through primary research, analysed and interpreted to get the final qualitative and quantitative data. This data is collected and added with detailed analysis from Envision Inteligence and presented in this report.
The scope of the Report
The human insulin market segmentation is as follows:
By Product Type
- HI Drugs
- HI Delivery Devices
By Type
- Insulin Analogs and Biosimilar
- Long-Acting Biosimilar
- Rapid-Acting Biosimilar
- Premixed Biosimilar
- HI Biologics
- Short-Acting Biologics
- Intermediate-Acting Biologics
- Premixed Biologics
By Brand
- HI Analogs and Biosimilar
- Lantus
- Novo rapid and Novo log
- Humalog
- Other Brands
- HI Biologics
- Actrapid, Mixtard, and Insulatard
- Humulin
- Insuman
By Delivery Devices
- Syringes
- Pens
- Disposable Pens
- Reusable Pens
- Pen Needles
- Standard Pen Needles
- Safety Pen Needles
By Application
- Type I Diabetes
- Type II Diabetes
Geographical Analysis:
Human insulin market is segmented by geography into North America, South America, Europe, Asia Pacific, and Middle East & Africa. U.S., Canada, Mexico and Costa Rica are analysed under North American region which is usually turning as the hotspot in the market. The South American region is further segregated into Brazil, Argentina, Chile, Columbia and some other emerging economies. In Europe, the market is extensively examined by covering U.K., Germany, France, Italy, Spain, Netherlands, Poland, Switzerland and some other promising economies. The Asia Pacific is further categorised by countries into China, India, Japan, South Korea, Australia & New
Zealand, Malaysia, Singapore and many other emerging nations. In the Middle East & African region, Saudi Arabia, UAE, Iran, Iraq, Qatar, South Africa, Algeria, Morocco, Nigeria and so on countries are evaluated to underst
